Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a Result of a Sterility Test Failure

Heritage Pharmaceuticals Inc. ( “Heritage”) East Brunswick, New Jersey, is initiating a voluntary recall of Amikacin Sulfate Injection and Prochlorperazine Edisylate Injection because of sterility issues.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news